Laurion Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-68,000	Closed	-$3.17M	–	728
2024 Q1	$3.17M	Buy	+68,000	New	+$3.21M	0.03%	298
2021 Q3	–	Sell	-2,918	Closed	-$278K	–	838
2021 Q2	$278K	Buy	+2,918	New	+$304K	﹤0.01%	600
2020 Q3	–	Sell	-6,848	Closed	-$536K	–	1099
2020 Q2	$536K	Buy	+6,848	New	+$453K	0.01%	605
2020 Q1	–	Sell	-17,515	Closed	-$748K	–	1025
2019 Q4	$748K	Sell	17,515 -9,685	-36%	-$400K	0.01%	622
2019 Q3	$1.16M	Buy	+27,200	New	+$1.48M	0.01%	613
2019 Q2	–	Sell	-19,823	Closed	-$1.38M	–	1130
2019 Q1	$1.38M	Buy	+19,823	New	+$1.13M	0.02%	462
2017 Q1	–	Sell	-2,900	Closed	-$204K	–	1530
2016 Q4	$204K	Buy	+2,900	New	+$206K	﹤0.01%	1001